Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,924,000 | 7,289,000 | 9,303,000 | 5,100,000 | 8,399,000 |
| Marketable Securities | N/A | 772,000 | 486,000 | 1,323,000 | 8,000 |
| Receivables | 5,428,000 | 5,384,000 | 5,088,000 | 4,758,000 | 4,730,000 |
| Inventories | 1,813,000 | 1,605,000 | 1,605,000 | 1,444,000 | 1,719,000 |
| TOTAL | $49,519,000 | $16,945,000 | $21,223,000 | $16,187,000 | $16,314,000 |
| Non-Current Assets | |||||
| PPE Net | 2,962,000 | 2,883,000 | 2,803,000 | 2,604,000 | 2,565,000 |
| Investments And Advances | 93,000 | 1,420,000 | 2,090,000 | 1,783,000 | 145,000 |
| Intangibles | 34,253,000 | 36,896,000 | 43,344,000 | 44,313,000 | 32,877,000 |
| Other Non-Current Assets | 2,288,000 | 1,208,000 | 1,326,000 | 1,212,000 | 1,149,000 |
| TOTAL | $39,596,000 | $42,407,000 | $49,563,000 | $49,912,000 | $36,736,000 |
| Total Assets | $89,115,000 | $59,352,000 | $70,786,000 | $66,099,000 | $53,050,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,753,000 | 5,308,000 | 6,415,000 | 402,000 | 2,431,000 |
| Accounts payable and accrued liabilities | 11,832,000 | 11,931,000 | 10,226,000 | 9,379,000 | 8,463,000 |
| TOTAL | $15,585,000 | $17,239,000 | $16,641,000 | $9,781,000 | $10,894,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 62,975,000 | 35,002,000 | 30,953,000 | 36,440,000 | 29,240,000 |
| Other Non-Current Liabilities | 17,597,000 | 14,490,000 | 15,605,000 | 8,352,000 | 3,695,000 |
| TOTAL | $81,702,000 | $50,559,000 | $49,048,000 | $51,682,000 | $38,211,000 |
| Total Liabilities | $97,287,000 | $67,798,000 | $65,689,000 | $61,463,000 | $49,105,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,479,157 | 1,475,084 | 1,587,973 | 1,593,920 | 1,611,238 |
| Common Shares | 18,000 | 18,000 | 18,000 | 18,000 | 17,000 |
| Retained earnings | 4,717,000 | 3,368,000 | 5,459,000 | 4,378,000 | 2,248,000 |
| Other shareholders' equity | -3,596,000 | -2,480,000 | -2,727,000 | -2,586,000 | -2,561,000 |
| TOTAL | $-8,172,000 | $-8,446,000 | $5,097,000 | $4,636,000 | $3,945,000 |
| Total Liabilities And Equity | $89,115,000 | $59,352,000 | $70,786,000 | $66,099,000 | $53,050,000 |